Found 4 matching trials
A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease
PHASE2The purpose of this study is to evaluate the efficacy and safety of PF 0449...
Location
Pfizer Investigational Site
6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent Albuminuria
PHASE2Current research indicates that TTP488 may be a viable agent for the treatm...
Location
Pfizer Investigational Site
Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
PHASE1To determine the safety and efficacy of using the drug azeliragon combined ...
Location
Miami Cancer Institute at Baptist Health, Inc.
A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients
PHASE2A 10-week safety and tolerability study of a potential treatment for mild t...
Location
Pfizer Investigational Site